Cardiogenic shock

Common Name(s)

Cardiogenic shock

Cardiogenic shock occurs when the heart has been damaged to the point where it cannot pump enough blood to the rest of the body. This condition is usually due to serious heart complications. These complications may occur during or after a severe heart attack and include damage to the heart muscle (stopping the heart from pumping), dangerous heart rhythms, pressure on the heart caused by fluid buildup, problems with the heart’s electrical system, a very slow heart rhythm, or damage to the heart valves (control flow of blood) or septums (walls which separate the four heart chambers).

Symptoms include rapid breathing and heartbeat (tachycardia), shortness of breath, and a loss of consciousness. Other symptoms include a weak pulse, sweating, pale skin, cold hands or feet, or urinating less than normal. About 7% of those who have a heart attack also develop cardiogenic shock.

Cardiogenic shock can also be caused by infections of the heart or a drug overdose. Other risk factors include diabetes, high blood pressure, coronary artery disease, smoking, lack of exercise, or a history of heart failure or heart attacks. Age and certain genetic and congenital (present at birth) conditions may also increase your risk.

Cardiogenic shock is a medical emergency. Tests to look for the cause may include a blood pressure test, EKG, echocardiogram, cardiac enzyme and other blood tests, chest X-ray, coronary angiograph, and cardiac catheterization. Increasing blood flow and oxygen to body’s organ is the most immediate focus. Further treatment will depend on the underlying cause but may include medication, insertion of a medical device (e.g. pacemakers) and surgery. Research is ongoing, so talk to your cardiologist about current treatment options if a family member has been diagnosed with cardiogenic shock. Support groups are a good source of information and support.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Cardiogenic shock" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Cardiogenic shock" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Cardiogenic shock" returned 422 free, full-text research articles on human participants. First 3 results:

Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock.
 

Author(s): Yesheng Pan, ZhiGang Lu, Jingyu Hang, Shixin Ma, Jian Ma, Meng Wei

Journal: Braz J Cardiovasc Surg. ;32(2):96-103.

 

The mortality due to cardiogenic shock complicating acute myocardial infarction (AMI) is high even in patients with early revascularization. Infusion of low dose recombinant human brain natriuretic peptide (rhBNP) at the time of AMI is well tolerated and could improve cardiac function.

Last Updated: 11 May 2017

Go To URL
Hemodynamic Analysis of Pediatric Septic Shock and Cardiogenic Shock Using Transpulmonary Thermodilution.
 

Author(s): En-Pei Lee, Shao-Hsuan Hsia, Jainn-Jim Lin, Oi-Wa Chan, Jung Lee, Chia-Ying Lin, Han-Ping Wu

Journal: Biomed Res Int. 2017 ;2017():3613475.

 

Septic shock and cardiogenic shock are the two most common types of shock in children admitted to pediatric intensive care units (PICUs). The aim of the study was to investigate which hemodynamic variables were associated with mortality in children with shock. We retrospectively analyzed ...

Last Updated: 12 Apr 2017

Go To URL
Prognostic Analysis for Cardiogenic Shock in Patients with Acute Myocardial Infarction Receiving Percutaneous Coronary Intervention.
 

Author(s): Mao-Jen Lin, Chun-Yu Chen, Hau-De Lin, Han-Ping Wu

Journal: Biomed Res Int. 2017 ;2017():8530539.

 

Cardiogenic shock (CS) is uncommon in patients suffering from acute myocardial infarction (AMI). Long-term outcome and adverse predictors for outcomes in AMI patients with CS receiving percutaneous coronary interventions (PCI) are unclear. A total of 482 AMI patients who received ...

Last Updated: 2 Mar 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Cardiogenic shock" returned 43 free, full-text review articles on human participants. First 3 results:

Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis.
 

Author(s): Dagmar M Ouweneel, Jasper V Schotborgh, Jacqueline Limpens, Krischan D Sjauw, A E Engström, Wim K Lagrand, Thomas G V Cherpanath, Antoine H G Driessen, Bas A J M de Mol, José P S Henriques

Journal: Intensive Care Med. 2016 Dec;42(12):1922-1934.

 

Veno-arterial extracorporeal life support (ECLS) is increasingly used in patients during cardiac arrest and cardiogenic shock, to support both cardiac and pulmonary function. We performed a systematic review and meta-analysis of cohort studies comparing mortality in patients treated ...

Last Updated: 20 Sep 2016

Go To URL
Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization.
 

Author(s): Hoong Sern Lim

Journal: Clin Cardiol. 2016 Aug;39(8):477-83.

 

Cardiogenic shock remains a highly lethal condition. Conventional therapy including revascularization and mechanical circulatory support aims to improve cardiac output and oxygen delivery, but increasing basic and clinical observations indicate wider circulatory and cellular abnormalities, ...

Last Updated: 24 Aug 2016

Go To URL
The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review.
 

Author(s): Xiao-Yun Zheng, Yi Wang, Yi Chen, Xi Wang, Lei Chen, Jun Li, Zhi-Gang Zheng

Journal:

 

Conflicting reports on the efficacy of intra-aortic balloon pump (IABP) during percutaneous coronary intervention (PCI) incited us to evaluate the utility of IABP in patients with acute myocardial infarction (AMI).

Last Updated: 9 Jul 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Cardiogenic Shock Intravascular Cooling Trial
 

Status: Not yet recruiting

Condition Summary: Cardiogenic Shock

 

Last Updated: 31 May 2017

Go to URL
ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock
 

Status: Recruiting

Condition Summary: Cardiogenic Shock

 

Last Updated: 25 Sep 2016

Go to URL
Microvasculature Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology
 

Status: Not yet recruiting

Condition Summary: Cardiogenic Shock

 

Last Updated: 13 Sep 2017

Go to URL